GLP-1 drugs, which include Ozempic and Wegovy, have become one of the most closely watched experimental approaches for slowing Alzheimer’s — a disease with few treatment options.
Tess Holliday said her body has been changing and she’s lost a little bit of weight recently. The model, 40, explained that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback